Literature DB >> 10160102

Cost considerations in the drug treatment of hypertension. Is older better?

N M Kaplan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 10160102     DOI： 10.2165/00019053-199609040-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  6 in total

1.  Cost-effectiveness of antihypertensive drugs. Fact or fancy?

Authors:  N M Kaplan
Journal:  Am J Hypertens       Date:  1991-05       Impact factor: 2.689

2.  The effect of prescribed daily dose frequency on patient medication compliance.

Authors:  S A Eisen; D K Miller; R S Woodward; E Spitznagel; T R Przybeck
Journal:  Arch Intern Med       Date:  1990-09

3.  The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

Authors: 
Journal:  Arch Intern Med       Date:  1993-01-25

4.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

5.  Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.

Authors:  D E Hilleman; S M Mohiuddin; B D Lucas; J A Stading; A M Stoysich; K Ryschon
Journal:  Clin Ther       Date:  1994 Jan-Feb       Impact factor: 3.393

6.  Quality-adjusted meta-analysis of the hypertension/coronary dilemma.

Authors:  I Holme; L G Ekelund; I Hjermann; P Leren
Journal:  Am J Hypertens       Date:  1994-08       Impact factor: 2.689
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.